Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

Also called NCT02071459

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02071459
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02071459. Randomized; quadruple masking; primary purpose treatment. Start 2014-01-21 (actual); primary completion 2019-10-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA
Acronym
DOPS-AMS
Condition
Multiple System Atrophy
Intervention (Drug)
L-Threo DOPS
Intervention (Drug)
placebo
Lead sponsor
University Hospital, Toulouse (class: other)

Record details

Record id
cardio:ct-nct02071459
Content hash
d62f1ace358178b1425f97fbd618b19181d3e5434a6bfc8bd5042ef8609f6325